REAP Financial Group’s FT Vest US Equity Deep Buffer ETF October DOCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.58M Sell
220,497
-42,338
-16% -$1.87M 1.89% 14
2025
Q4
$11.6M Sell
262,835
-38,742
-13% -$1.7M 2.36% 10
2025
Q3
$13M Sell
301,577
-18,899
-6% -$795K 2.83% 9
2025
Q2
$13.2M Sell
320,476
-166,594
-34% -$6.5M 3.09% 6
2025
Q1
$18.7M Sell
487,070
-70,074
-13% -$2.76M 4.63% 4
2024
Q4
$21.9M Buy
557,144
+338,302
+155% +$13.3M 5.44% 4
2024
Q3
$8.54M Sell
218,842
-12,118
-5% -$469K 2.09% 15
2024
Q2
$8.87M Sell
230,960
-4,041
-2% -$153K 2.38% 15
2024
Q1
$8.84M Sell
235,001
-2,328
-1% -$86.2K 2.43% 9
2023
Q4
$8.63M Buy
+237,329
New +$8.36M 2.51% 11

Other funds holding DOCT

REAP Financial Group's DOCT Position: Q1 2026 in Review

REAP Financial Group reduced its FT Vest US Equity Deep Buffer ETF October (DOCT) stake by 16% in Q1 2026, selling an estimated $1.87M and leaving 220,497 shares worth $9.58M. The position accounts for 1.89% of the portfolio, ranked #14.

REAP Financial Group first reported a position in DOCT in Q4 2023 and has held it in 10 quarters since. The position peaked at $21.9M in Q4 2024. 111 funds tracked by Wall St. Rank hold DOCT as of Q1 2026.

  • REAP Financial Group held 220,497 shares of FT Vest US Equity Deep Buffer ETF October worth $9.58M as of Q1 2026.
  • REAP Financial Group sold 42,338 FT Vest US Equity Deep Buffer ETF October shares in Q1 2026, an estimated $1.87M.
  • FT Vest US Equity Deep Buffer ETF October made up 1.89% of REAP Financial Group's portfolio in Q1 2026, its #14 holding.
  • REAP Financial Group first reported a position in FT Vest US Equity Deep Buffer ETF October in Q4 2023 and has held it in 10 quarters since.
  • REAP Financial Group's FT Vest US Equity Deep Buffer ETF October position peaked at $21.9M in Q4 2024.
  • 111 funds tracked by Wall St. Rank held FT Vest US Equity Deep Buffer ETF October as of Q1 2026.

Based on REAP Financial Group's 13F filing for Q1 2026, filed 11 May 2026.